Non-steroidal anti-inflammatory drugs in the carcinogenesis of the gastrointestinal tract

9Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

It is estimated that underlying infections and inflammatory responses are linked to 15-20% of all deaths from cancer worldwide. Inflammation is a physiologic process in response to tissue damage resulting from microbial pathogen infection, chemical irritation, and/or wounding. Tissues injured throughout the recruitment of inflammatory cells such as macrophages and neutrophils, generate a great amount of growth factors, cytokines, and reactive oxygen and nitrogen species that may cause DNA damage that in turn predisposes to the transformation from chronic inflammation to neoplasia. Cyclooxygenase (COX), playing a key role in cell homeostasis, angiogenesis and tumourigenesis, may represent the link between inflammation and cancer. Currently COX is becoming a pharmacological target for cancer prevention and treatment. © 2010 by the authors.

Cite

CITATION STYLE

APA

Compare, D., Nardone, O., & Nardone, G. (2010). Non-steroidal anti-inflammatory drugs in the carcinogenesis of the gastrointestinal tract. Pharmaceuticals, 3(8), 2495–2516. https://doi.org/10.3390/ph3082495

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free